NCT03557437View on ClinicalTrials.gov

High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

May 25, 2018

Primary Completion Date

June 10, 2019

Study Completion Date

June 10, 2019

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Esomeprazole

Proton pump inhibitor

DRUG

Amoxicillin, Metronidazole

Antibiotics for H. pylori eradication

DRUG

Bismuth Potassium Citrate

Gastric mucosal protective drug with anti-H. pylori effect

Trial Locations (1)

200127

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT03557437 - High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment | Biotech Hunter | Biotech Hunter